Scott R. Eberhardy

753 total citations
7 papers, 598 citations indexed

About

Scott R. Eberhardy is a scholar working on Molecular Biology, Virology and Oncology. According to data from OpenAlex, Scott R. Eberhardy has authored 7 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Virology and 2 papers in Oncology. Recurrent topics in Scott R. Eberhardy's work include RNA Interference and Gene Delivery (3 papers), Genomics and Chromatin Dynamics (3 papers) and HIV Research and Treatment (2 papers). Scott R. Eberhardy is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), Genomics and Chromatin Dynamics (3 papers) and HIV Research and Treatment (2 papers). Scott R. Eberhardy collaborates with scholars based in United States, Portugal and Netherlands. Scott R. Eberhardy's co-authors include Peggy Farnham, João Gonçalves, David J. Segal, Carlos F. Barbas, Xuelin Li, Bruce E. Torbett, Liu Z, Ben Berkhout, Warren Heideman and Jinnie M. Garrett and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Journal of Bacteriology.

In The Last Decade

Scott R. Eberhardy

7 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott R. Eberhardy United States 7 532 113 79 63 60 7 598
Ming‐Chih Lai Taiwan 11 780 1.5× 45 0.4× 69 0.9× 61 1.0× 64 1.1× 11 877
Ryouji Fujii Japan 11 436 0.8× 44 0.4× 35 0.4× 47 0.7× 56 0.9× 14 494
Karine Boulay Canada 8 437 0.8× 36 0.3× 61 0.8× 139 2.2× 50 0.8× 9 549
Adam Langenbucher United States 8 333 0.6× 118 1.0× 43 0.5× 160 2.5× 72 1.2× 12 463
Tony M. Mertz United States 14 630 1.2× 118 1.0× 49 0.6× 217 3.4× 115 1.9× 19 726
Thierry Seroz France 7 640 1.2× 182 1.6× 28 0.4× 45 0.7× 69 1.1× 8 703
Artem G. Lada United States 14 518 1.0× 82 0.7× 23 0.3× 177 2.8× 94 1.6× 19 600
Brook C. Barajas United States 6 413 0.8× 49 0.4× 21 0.3× 101 1.6× 45 0.8× 7 528
Emily M. Gesner Canada 10 751 1.4× 65 0.6× 17 0.2× 90 1.4× 54 0.9× 14 811
Barbara Studamire United States 10 574 1.1× 41 0.4× 81 1.0× 74 1.2× 110 1.8× 11 629

Countries citing papers authored by Scott R. Eberhardy

Since Specialization
Citations

This map shows the geographic impact of Scott R. Eberhardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott R. Eberhardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott R. Eberhardy more than expected).

Fields of papers citing papers by Scott R. Eberhardy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott R. Eberhardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott R. Eberhardy. The network helps show where Scott R. Eberhardy may publish in the future.

Co-authorship network of co-authors of Scott R. Eberhardy

This figure shows the co-authorship network connecting the top 25 collaborators of Scott R. Eberhardy. A scholar is included among the top collaborators of Scott R. Eberhardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott R. Eberhardy. Scott R. Eberhardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Eberhardy, Scott R., et al.. (2009). Iron (III) citrate inhibits polyethylenimine-mediated transient transfection of Chinese hamster ovary cells in serum-free medium. Cytotechnology. 60(1-3). 1–9. 21 indexed citations
2.
Eberhardy, Scott R., et al.. (2006). Inhibition of Human Immunodeficiency Virus Type 1 Replication with Artificial Transcription Factors Targeting the Highly Conserved Primer-Binding Site. Journal of Virology. 80(6). 2873–2883. 42 indexed citations
3.
Segal, David J., João Gonçalves, Scott R. Eberhardy, et al.. (2004). Attenuation of HIV-1 Replication in Primary Human Cells with a Designed Zinc Finger Transcription Factor. Journal of Biological Chemistry. 279(15). 14509–14519. 72 indexed citations
4.
Eberhardy, Scott R. & Peggy Farnham. (2002). Myc Recruits P-TEFb to Mediate the Final Step in the Transcriptional Activation of the cad Promoter. Journal of Biological Chemistry. 277(42). 40156–40162. 200 indexed citations
5.
Eberhardy, Scott R. & Peggy Farnham. (2001). c-Myc Mediates Activation of the cad Promoter via a Post-RNA Polymerase II Recruitment Mechanism. Journal of Biological Chemistry. 276(51). 48562–48571. 163 indexed citations
6.
Eberhardy, Scott R., et al.. (2000). Direct Examination of Histone Acetylation on Myc Target Genes Using Chromatin Immunoprecipitation. Journal of Biological Chemistry. 275(43). 33798–33805. 79 indexed citations
7.
Garrett, Jinnie M., et al.. (1995). Activation of the Ras/cyclic AMP pathway in the yeast Saccharomyces cerevisiae does not prevent G1 arrest in response to nitrogen starvation. Journal of Bacteriology. 177(23). 6761–6765. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026